Johnson & Johnson (JNJ) insider trading

By person

32 insiders · 433 transactions

52.6×

J. Duato holds 52.6 times base salary in stock. $84.30M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what J. Duato last reported holding, valued at $274.74, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Joaquin Duato

CEO and Chairman of the Board

—

$101.34M (9) scheduled

−$101.34M

306,819

0.0127%

$84.30M

+539.7%

Peter Fasolo

Exec VP, Chief HR Officer

—

$52.78M (280)

−$52.78M

112,076

0.0047%

$30.79M

+127.5%

Alex Gorsky

Director

—

$38.60M (1) scheduled

−$38.60M

766,584

0.0318%

$210.61M

+333.1%

Jennifer L Taubert

EVP, WWC. Innovative Medicine

—

$36.87M (4) scheduled

−$36.87M

194,451

0.0081%

$53.42M

+198.9%

Paulus Stoffels

Vice Chair, Exec Committee

—

$36.43M (3) scheduled

−$36.43M

275,547

0.0114%

$75.70M

+124.5%

Joseph J Wolk

Exec VP, CFO

—

$29.40M (8) scheduled

−$29.40M

82,835

0.0034%

$22.76M

+714.7%

Michael E Sneed

EVP, Global Corp Aff & CCO

—

$25.36M (4) scheduled

−$25.36M

62,177

0.0026%

$17.08M

+55.9%

John C Reed

EVP, Innovative Medicine, R&D

—

$20.42M (5) scheduled

−$20.42M

24,911

0.0010%

$6.84M

+653.5%

Thibaut Mongon

Exec VP, WW Chair, Cons Health

—

$17.93M (40) scheduled

−$17.93M

65,915

0.0027%

$18.11M

+23.1%

Ashley McEvoy

EVP, WW Chair, MedTech

—

$17.14M (3) scheduled

−$17.14M

54,253

0.0023%

$14.91M

+355.1%

Kathryn E Wengel

EVP, Chief TO and Risk Officer

—

$16.93M (10) scheduled

−$16.93M

114,288

0.0047%

$31.40M

+169.0%

James D. Swanson

EVP, CIO

—

$15.27M (4) scheduled

−$15.27M

25,698

0.0011%

$7.06M

+2,205%

Timothy Schmid

EVP, WW Chair, MedTech

—

$15.15M (6) scheduled

−$15.15M

26,251

0.0011%

$7.21M

+168.3%

Dominic J Caruso

Exec VP, Finance; CFO

—

$11.29M (1) scheduled

−$11.29M

171,659

0.0071%

$47.16M

+47.1%

William Hait

EVP, Chief EI and Med Officer

—

$10.55M (11) scheduled

−$10.55M

38,647

0.0016%

$10.62M

+141.6%

Robert J Decker

VP Corporate Controller

—

$9.28M (9) scheduled

−$9.28M

23,682

0.0010%

$6.51M

+90.3%

Vanessa Broadhurst

EVP, Global Corp Affairs

—

$8.74M (3) scheduled

−$8.74M

23,003

0.0010%

$6.32M

+84.2%

Ronald A Kapusta

Controller, CAO

—

$4.62M (4)

−$4.62M

17,757

0.0007%

$4.88M

−31.0%

Elizabeth Forminard

EVP, Chief Legal Officer

—

$4.09M (2) scheduled

−$4.09M

16,994

0.0007%

$4.67M

+429.2%

Michael H Ullmann

Exec VP, General Counsel

—

$2.45M (1) scheduled

−$2.45M

158,835

0.0066%

$43.64M

+73.7%

Gary J Pruden

Exec VP, WW Chair, Med Devices

—

$1.99M (1)

−$1.99M

43,630

0.0018%

$11.99M

0.0%

Hubert Joly

Director

$706.40K (1)

—

+$706.40K

5,000

0.0002%

$1.37M

—

Marillyn A Hewson

Director

$419.04K (1)

—

+$419.04K

3,000

0.0001%

$824.22K

—

Charles Prince

Director

$268.73K (1)

—

+$268.73K

28,520

0.0012%

$7.84M

+7.5%

John G Morikis

Director

$257.69K (1)

—

+$257.69K

1,849

<0.0001%

$507.86K

+208.9%

William D Perez

Director

$197.75K (2)

—

+$197.75K

25,130

0.0010%

$6.90M

−12.5%

Mark A Weinberger

Director

$147.22K (1)

—

+$147.22K

1,000

<0.0001%

$274.74K

—

Anne M Mulcahy

Director

$100.05K (1)

—

+$100.05K

6,537

0.0003%

$1.80M

+12.9%

Sandra E Peterson

Exec VP, Group WW Chairman

—

83,349

0.0035%

$22.90M

+133.8%

Mathai Mammen

EVP, Pharm, R&D

—

41,934

0.0017%

$11.52M

+29.1%

Jorge S. Mesquita

Exec VP, WW Chair, Consumer

—

27,344

0.0011%

$7.51M

—

Kristen Mulholland

EVP, Chief HR Officer

—

19,830

0.0008%

$5.45M

+69.6%

Johnson & Johnson

What the insiders did Net selling

By person